Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma-Reference-Cited by-同舟云学术

Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma

Published:2003-10-03 Issue:8 Volume:98 Page:1707-1715
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

De Marinis Filippo,Nelli Fabrizio,Migliorino Maria Rita,Martelli Olga,Cortesi Enrico,Treggiari Stefano,Portalone Luigi,Crispino Carlo,Brancaccio Luigi,Gridelli Cesare

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference31 articles.

1. Revisions in the International System for Staging Lung Cancer

2. Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and Implications

3. The Role of Surgery in N2 Lung Cancer

4. Multimodality therapy in stage III non—small cell lung cancer

5. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updated review of perioperative treatment for non-small-cell lung cancer in the new era of immune checkpoint inhibitors: past, present, and future;Japanese Journal of Clinical Oncology;2024-08-20

2. Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell lung cancer: A systematic review and single-arm meta-analysis;Frontiers in Oncology;2022-09-21

3. Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer;Frontiers in Oncology;2018-01-23

4. Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer;Japanese Journal of Clinical Oncology;2017-11-09

5. Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment;OncoTargets and Therapy;2016-06